
Alcon AG (NYSE:ALC)

Intrinsic Value
The intrinsic value of one
ALC
stock under the Base Case scenario is
67.15
USD.
Compared to the current market price of 68.65 USD,
Alcon AG
is
Overvalued by 2%.
The Intrinsic Value is calculated as the average of the two valuation methods:

Fundamental Analysis
ALC Profitability Score
Profitability Due Diligence
Alcon AG's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
Alcon AG's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
ALC Solvency Score
Solvency Due Diligence
Alcon AG's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Score
Alcon AG's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Wall Street
Price Targets
ALC Price Targets
Price Targets made by Wall Street
12-month price targets for ALC stock made by Wall Street professionals. The average price target is 84.49 USD with a low forecast of 66.9 USD and a high forecast of 97.8 USD.
Insider Trading
ALC Insider Trading
Buy and sell transactions by insiders
Company Profile

Country
Industry
Market Cap
Dividend Yield
Description
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. The company is headquartered in Fribourg, Fribourg and currently employs 24,389 full-time employees. The company went IPO on 2019-04-09. The firm operates mainly as an eye care device company. Alcon AG reports its activities into two segments: Surgical and Vision Care. The surgical segment provides a line of ophthalmic surgical products that enable surgeons to achieve accurate results. Its surgical portfolio includes technologies and devices for cataract, retinal, refractive surgery, as well as advanced technology intraocular lenses (ATIOLs) to treat cataracts and refractive errors, such as presbyopia and astigmatism. The surgical segment also includes advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery. The Vision Care segment manufactures contact lenses and lens care products, such as products for dry eye, contact lens care, ocular allergies, as well as ocular vitamins and redness relievers. The firm also offers continuing education for eye care professionals.
Contact
IPO
Employees
Officers
ALC Stock FAQ
The intrinsic value of one
ALC
stock under the Base Case scenario is
67.15
USD.
Compared to the current market price of 68.65 USD, Alcon AG is Overvalued by 2%.